Voloridge Investment Management
JAZZ icon

Voloridge Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Voloridge Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,460
Closed -$6.51M – 1267
2025
Q1 		$6.51M Buy
+52,460
New +$6.84M 0.02% 704
2024
Q2 		– Sell
-11,849
Closed -$1.43M – 1292
2024
Q1 		$1.43M Buy
+11,849
New +$1.45M 0.01% 914
2023
Q4 		– Sell
-1,594
Closed -$206K – 1314
2023
Q3 		$206K Sell
1,594
-5,713
-78% -$761K ﹤0.01% 1320
2023
Q2 		$906K Buy
+7,307
New +$983K ﹤0.01% 1139
2022
Q1 		– Sell
-3,873
Closed -$493K – 1546
2021
Q4 		$493K Buy
+3,873
New +$509K ﹤0.01% 1409
2021
Q2 		– Sell
-1,258
Closed -$207K – 1692
2021
Q1 		$207K Sell
1,258
-16,384
-93% -$2.7M ﹤0.01% 1322
2020
Q4 		$2.91M Buy
+17,642
New +$2.63M 0.02% 615
2020
Q1 		– Sell
-58,939
Closed -$8.8M – 1236
2019
Q4 		$8.8M Buy
58,939
+46,488
+373% +$6.33M 0.17% 152
2019
Q3 		$1.59M Buy
+12,451
New +$1.67M 0.03% 515
2019
Q1 		– Sell
-26,377
Closed -$3.27M – 994
2018
Q4 		$3.27M Buy
+26,377
New +$3.91M 0.15% 147
2018
Q1 		– Sell
-88,750
Closed -$11.9M – 569
2017
Q4 		$11.9M Buy
+88,750
New +$12.3M 0.26% 94
2016
Q2 		– Sell
-54,053
Closed -$7.06M – 355
2016
Q1 		$7.06M Buy
+54,053
New +$6.73M 0.17% 126
2015
Q4 		– Sell
-48,581
Closed -$6.45M – 242
2015
Q3 		$6.45M Buy
+48,581
New +$8.36M 0.3% 85
2014
Q1 		– Sell
-24,005
Closed -$3.04M – 107
2013
Q4 		$3.04M Buy
+24,005
New +$2.48M 0.58% 54

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Voloridge Investment Management's JAZZ Position: Q2 2025 in Review

Voloridge Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 52,460 shares — an estimated $6.51M sold.

Voloridge Investment Management first reported a position in JAZZ in Q4 2013 and held it in 14 quarters. The position peaked at $11.9M in Q4 2017. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Voloridge Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 52,460 Jazz Pharmaceuticals shares in Q2 2025, an estimated $6.51M.
  • Voloridge Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • Voloridge Investment Management's Jazz Pharmaceuticals position peaked at $11.9M in Q4 2017.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.